SERPINC1 and Thromboembolism: Since there is an increased risk for thromboembolism in diabetics [36], we speculate that this may be related to increased glycosylation of AT-III, resulting in more of the glycosylated α-AT-III isomer, which has less anticoagulant activity than the less glycosylated β-AT-III.